Ncage TherapeuticsS.A.Status: Entity active

Ncage Therapeutics is developing synthetic protein cages based on the bacterial TRAP protein, which can display biological material or transport molecules like nucleic acids and proteins into cells. Their platform includes programmable opening and closing features for loading and releasing cargo, such as proteins and small molecule drugs. The company focuses on applications in synthetic viral-like particle vaccines and enhancing the safety profile of antibody-drug conjugates for cancer treatment.